A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDS

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

Not specified

Study Completion Date

September 30, 1994

Conditions
HIV InfectionsHistoplasmosis
Interventions
DRUG

Itraconazole

Trial Locations (12)

10021

Cornell University A2201, New York

14642

Univ. of Rochester ACTG CRS, Rochester

27710

Duke Univ. Med. Ctr. Adult CRS, Durham

45267

Univ. of Cincinnati CRS, Cincinnati

46202

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis

55455

University of Minnesota, ACTU, Minneapolis

60611

Northwestern University CRS, Chicago

70112

Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU, New Orleans

90033

USC CRS, Los Angeles

Unknown

Washington U CRS, St Louis

The Ohio State Univ. AIDS CRS, Columbus

Pitt CRS, Pittsburgh

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Janssen Pharmaceuticals

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH